Inventor · disambiguated record
Samir Messaoudi
Also filed as: MESSAOUDI SAMIR
8 granted patents·2 pending applications·5 citations·filing 2008–2023
76Inventor score
Files withINST NAT SANTE RECH MED3ADPUERIVITAM1ALAMI MOUAD1CENTRE NAT RECH SCIENT1CT NAT DE LA RECH SCIENRIFIQUE CNRS1
Top patents by PatentIndex Score
10 records- 0183US11376245B2Dizocilpine derivatives as peripheral NMDA receptor antagonistsINST NAT SANTE RECH MED·Filed 2017·Granted Jul 5, 2022·3 cites·14 claims
- 0278US12274694B2Dizocilpine derivatives as peripheral NMDA receptor antagonistsINST NAT SANTE RECH MED·Filed 2023·Granted Apr 15, 2025·0 cites·8 claims
- 0368US11944616B2Dizocilpine derivatives as peripheral NMDA receptor antagonistsINSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICAL INSERM·Filed 2022·Granted Apr 2, 2024·0 cites·14 claims
- 0459US8273768B2Iso CA-4 and analogues thereof as potent cytotoxic agents inhibiting tubuline polymerizationALAMI MOUAD·Filed 2008·Granted Sep 25, 2012·2 cites·20 claims
- 0546US2020253996A1Tctp inhibiting agents for the treatment of proliferative diseases, infectious diseases, allergies, inflammations and/or asthmaUNIV PARIS-SUD·Filed 2018·Application pending·0 cites
- 0645US12213978B2Madrasin-derivative compounds, composition and uses thereof for treating cancerROUSSY INST GUSTAVE·Filed 2019·Granted Feb 4, 2025·0 cites·15 claims
- 0745US2011160228A1Dihydro-iso-ca-4 and analogues: potent cytotoxics, inhibitors of tubulin polymerizationCT NAT DE LA RECH SCIENRIFIQUE CNRS·Filed 2009·Application pending·0 cites
- 0835US10538482B2Adamantane and memantine derivatives as peripheral NMDA receptor antagonistsINST NAT SANTE RECH MED·Filed 2016·Granted Jan 21, 2020·0 cites·16 claims
- 0932US10653694B2Cytotoxic compounds which are inhibitors of the polymerisation of tubulinCENTRE NAT RECH SCIENT·Filed 2015·Granted May 19, 2020·0 cites·16 claims
- 1026US11247982B2NMDA receptor modulators, compositions comprising same and use of these compounds in the treatment of diseases involving the central nervous systemADPUERIVITAM·Filed 2018·Granted Feb 15, 2022·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Samir Messaoudi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →